In brief, patients with LS primary tumors were primarily characterized by male sex (p = 0.000), a higher rate of preoperative chemotherapy (p = 0.017) and a lower chance of RAS/BRAF mutations (p = 0.000). The gene discussed is BRAF; the disease is Leigh syndrome.